These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14009526)

  • 21. Fine structural studies in myasthenia gravis. II. Lesions of the neuromuscular junction.
    Korényi-Both A; Szobor A; Lapis K; Szathmáry I
    Eur Neurol; 1973; 10(5):311-23. PubMed ID: 4789107
    [No Abstract]   [Full Text] [Related]  

  • 22. [The ultrastructure of axomuscular synapses in myasthenia].
    Kuzin MI; Mitin KS; Sekamova SM
    Arkh Patol; 1972; 34(9):35-41. PubMed ID: 4645152
    [No Abstract]   [Full Text] [Related]  

  • 23. What is in the Neuromuscular Junction Literature?
    Lacomis D; Puwanant A
    J Clin Neuromuscul Dis; 2018 Dec; 20(2):76-84. PubMed ID: 30439753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenic-like features of the neuromuscular transmission failure produced by triethylcholine.
    BOWMAN WC; HEMSORTH BA; RAND MJ
    J Pharm Pharmacol; 1962 Dec; 14(Suppl)():37T-41T. PubMed ID: 14014655
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurogenic changes in myasthenia gravis.
    Isaacs H; Badenhorst M
    S Afr Med J; 1974 Aug; 48(42):1783-9. PubMed ID: 4278873
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ultrastructure of the thymus and neuromuscular junction in myasthenic and non-myasthenic patients].
    Szekamova S; Répássy G; Lapis K; Szobor A; Szathmáry I
    Morphol Igazsagugyi Orv Sz; 1978 Apr; 18(2):107-16. PubMed ID: 714044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Is in the Neuromuscular Junction Literature?
    Lacomis D; Wolfe GI
    J Clin Neuromuscul Dis; 2021 Mar; 22(3):147-154. PubMed ID: 33595998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myasthenia].
    Bouhour F; Confavreux C
    Rev Prat; 2005 Nov; 55(17):1927-32. PubMed ID: 16396237
    [No Abstract]   [Full Text] [Related]  

  • 30. An electrophysiologic study of the neuromuscular junction in myasthenia gravis.
    DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S
    J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322
    [No Abstract]   [Full Text] [Related]  

  • 31. Complement associated pathogenic mechanisms in myasthenia gravis.
    Tüzün E; Christadoss P
    Autoimmun Rev; 2013 Jul; 12(9):904-11. PubMed ID: 23537510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic polymyositis with electrophysiological characteristics of myasthenia gravis and myasthenic syndrome. A case report (author's transl)].
    Nakano T; Shindo M; Oguchi K; Yanagisawa N; Tsukagoshi H
    Rinsho Shinkeigaku; 1980 Feb; 20(2):100-6. PubMed ID: 7371329
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathology of the neuromuscular junction.
    Zacks SI
    Ann Clin Lab Sci; 1975; 5(3):161-6. PubMed ID: 49168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrastructure of the neuromuscular junction in myasthenia].
    Pozaniakov OM; Babakova LL; Kolomenskaia EA; Kuz'min NV
    Arkh Patol; 1975; 37(10):55-63. PubMed ID: 1225269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromusclar junction and myasthenic crisis.
    Mayer RF; Albuquerque EX; Rash JE; Hudson CS
    Trans Am Neurol Assoc; 1977; 102():100-4. PubMed ID: 616082
    [No Abstract]   [Full Text] [Related]  

  • 37. Freeze fracture studies of human neuromuscular junctions. Membrane alterations observed in myasthenia gravis.
    Rash JE; Hudson CS; Graham WF; Mayer RF; Warnick JE; Albuquerque EX
    Lab Invest; 1981 Jun; 44(6):519-30. PubMed ID: 7230737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.
    NASTUK WL; STRAUSS AJ; OSSERMAN KE
    Am J Med; 1959 Mar; 26(3):394-409. PubMed ID: 13626994
    [No Abstract]   [Full Text] [Related]  

  • 39. Myasthenia gravis: a new hypothesis of the pathogenesis and a new form of treatment.
    Engel WK; Warmolts JR
    Ann N Y Acad Sci; 1971 Sep; 183():72-87. PubMed ID: 4107830
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuromuscular transmission in myasthenia gravis.
    CHURCHILL-DAVIDSON HC; RICHARDSON AT
    J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.